REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Drug: Nivolumab;   Radiation: Radiotherapy (RT)
Sponsors:   Oslo University Hospital;   Bristol-Myers Squibb
Recruiting

http://ift.tt/2y02cSc